Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTNZPQ1)

• DTT Name: GABA(A) receptor alpha-5 (GABRA5) DTT Info
• Gene Name: GABRA5

Molecule-Related Drug & Molecule List

1 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Flumazenil	DMPCG2L	Benzodiazepine overdose	PC91	Approved	[1]

3 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Basmisanil	DMQ8J0U	Alzheimer disease	8A20	Phase 2	[2]
GSK683699	DMTW79H	Inflammatory bowel disease	DD72	Phase 2	[3]
RG-7816	DMD16JK	Autism spectrum disorder	6A02	Phase 1	[4]

38 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
(2E,4S)-4-ammoniopent-2-enoate	DMA9RIS	Discovery agent	N.A.	Investigative	[5]
(4R)-4-ammoniopentanoate	DMZFTI4	Discovery agent	N.A.	Investigative	[5]
(4S)-4-ammoniopentanoate	DMBLAY1	Discovery agent	N.A.	Investigative	[5]
3-(3-Methyl-butoxy)-9H-beta-carboline	DMTNCXP	Discovery agent	N.A.	Investigative	[6]
3-(benzyloxy)-9H-pyrido[3,4-b]indole	DMDNEKR	Discovery agent	N.A.	Investigative	[6]
3-(hexa-1,3-dienyloxy)-9H-pyrido[3,4-b]indole	DMKHNTY	Discovery agent	N.A.	Investigative	[6]
3-Butoxy-9H-beta-carboline	DMQ8H74	Discovery agent	N.A.	Investigative	[6]
3-Ethoxy-9H-beta-carboline	DM6K7BI	Discovery agent	N.A.	Investigative	[6]
3-Isobutoxy-9H-beta-carboline	DM6X5TZ	Discovery agent	N.A.	Investigative	[6]
3-Propoxy-9H-beta-carboline	DMDEV64	Discovery agent	N.A.	Investigative	[6]
5-[(1R)-1-ammonioethyl]isoxazol-3-olate	DM23PL4	Discovery agent	N.A.	Investigative	[5]
5-[(1S)-1-ammonioethyl]isoxazol-3-olate	DMYAPLT	Discovery agent	N.A.	Investigative	[5]
9H-beta-Carboline-3-carboxylic acid ethyl ester	DMK459I	Discovery agent	N.A.	Investigative	[6]
alpha3IA	DM257WX	Discovery agent	N.A.	Investigative	[1]
alpha5IA	DMTU5QR	Discovery agent	N.A.	Investigative	[1]
AMENTOFLAVONE	DMLRNV2	Discovery agent	N.A.	Investigative	[7]
Barbituric acid derivative	DM2I19P	Discovery agent	N.A.	Investigative	[8]
Beta-Carboline-3-carboxylic acid t-butyl ester	DM9LT60	N. A.	N. A.	Investigative	[6]
CI-218872	DM0RH3S	Discovery agent	N.A.	Investigative	[6]
DMCM	DMK3WY4	Discovery agent	N.A.	Investigative	[1]
Ethyl 6-iodo-9H-pyrido[3,4-b]indole-3-carboxylate	DM5G91Z	Discovery agent	N.A.	Investigative	[6]
HT-2678	DMRF73O	Cognitive impairment	6D71	Investigative	[1]
isonipecotic acid	DMO1ZHE	Discovery agent	N.A.	Investigative	[1]
L-655708	DM4CDIB	Discovery agent	N.A.	Investigative	[9]
piperidine-4-sulphonic acid	DMMIZWE	Discovery agent	N.A.	Investigative	[1]
Ro-15-3505	DM4NW3U	Discovery agent	N.A.	Investigative	[10]
Ro-4938581	DMCB2N9	Discovery agent	N.A.	Investigative	[11]
RY024	DM9KXV0	Discovery agent	N.A.	Investigative	[1]
Sec-butyl 9H-pyrido[3,4-b]indole-3-carboxylate	DM9QSDC	Discovery agent	N.A.	Investigative	[6]
TBPS	DMFC3XP	Discovery agent	N.A.	Investigative	[1]
tetrahydrodeoxycorticosterone	DMF8M0W	Discovery agent	N.A.	Investigative	[1]
TP003	DMRHDGN	Discovery agent	N.A.	Investigative	[1]
[18F]fluoroethylflumazenil	DMPWART	Discovery agent	N.A.	Investigative	[1]
[35S]TBPS	DMSD51L	Discovery agent	N.A.	Investigative	[1]
[3H]CGS8216	DMLP68J	Inflammation	1A00-CA43.1	Investigative	[1]
[3H]L655708	DMUZ9LX	Discovery agent	N.A.	Investigative	[1]
[3H]Ro154513	DMMBWKL	Discovery agent	N.A.	Investigative	[12]
[3H]RY80	DMJKWNY	Discovery agent	N.A.	Investigative	[13]

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 408).
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [3] New anticonvulsants: Schiff bases of gamma-aminobutyric acid and gamma-aminobutyramide. J Med Chem. 1980 Jun;23(6):702-4.
• [4] Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357.
• [5] gamma-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects. J Med Chem. 1981 Dec;24(12):1377-83.
• [6] Design, synthesis, and subtype selectivity of 3,6-disubstituted -carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents f... Bioorg Med Chem. 2010 Nov 1;18(21):7548-64.
• [7] Semisynthetic preparation of amentoflavone: A negative modulator at GABA(A) receptors. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2281-4.
• [8] Whiting PJ: The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Devel. 2003 Sep;6(5):648-57.
• [9] 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor li... J Med Chem. 2004 Mar 25;47(7):1807-22.
• [10] The GABA(A) receptor as a target for photochromic molecules. Bioorg Med Chem. 2010 Nov 15;18(22):7731-8.
• [11] The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment... Bioorg Med Chem Lett. 2009 Oct 15;19(20):5940-4.
• [12] Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for alpha 5-containing GABA... J Med Chem. 1996 Apr 26;39(9):1928-34.
• [13] [3H]RY 80: A high-affinity, selective ligand for gamma-aminobutyric acidA receptors containing alpha-5 subunits. J Pharmacol Exp Ther. 1997 Nov;283(2):488-93.